Publications
- A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions2019 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Comparison of five different scoring methods in the evaluation of inflammatory infiltration (tumor-infiltrating lymphocytes) in superficial spreading and nodular melanoma2019 | First Faculty of Medicine
- Evaluation of inflammatory cells (tumor infiltrating lymphocytes - TIL) in malignant melanoma2018 | First Faculty of Medicine
- Evaluation of Inflammatory Cells (Tumor Infiltrating Lymphocytes) in Solid Tumors2017 | First Faculty of Medicine
- Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases2024 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Somatic genomic and transcriptomic characterization of primary ovarian serous borderline tumors and low-grade serous carcinomas2024 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine
- A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
Loading network view...